NCT02758691View on ClinicalTrials.gov

fMRI Study of Effects of Nasal Insulin on Memory

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

May 10, 2017

Conditions
Human MemoryIntranasal Insulin
Interventions
DRUG

Intranasal Insulin

All participants in the devise testing portion of the study will self-administer a 20 IU dose of intranasal insulin. Half of the participants in the function Magnetic Resonance Imaging portion of the study will also self-administer a 20 IU dose of intranasal insulin.

DRUG

Intranasal Saline

All participants in the devise testing portion of the study will self-administer a 20 mL dose of intranasal saline. Half of the participants in the function Magnetic Resonance Imaging portion of the study will also self-administer a 20 mL dose of intranasal saline.

All Listed Sponsors
lead

Virginia Polytechnic Institute and State University

OTHER

NCT02758691 - fMRI Study of Effects of Nasal Insulin on Memory | Biotech Hunter | Biotech Hunter